223 related articles for article (PubMed ID: 26781373)
21. Semi-automated repetitive sequence-based PCR amplification for species of the Scedosporium apiospermum complex.
Matray O; Mouhajir A; Giraud S; Godon C; Gargala G; Labbé F; Rougeron A; Ballet JJ; Zouhair R; Bouchara JP; Favennec L
Med Mycol; 2016 May; 54(4):409-19. PubMed ID: 26486722
[TBL] [Abstract][Full Text] [Related]
22. Multilocus sequence typing of Scedosporium apiospermum and Pseudallescheria boydii isolates from cystic fibrosis patients.
Bernhardt A; Sedlacek L; Wagner S; Schwarz C; Würstl B; Tintelnot K
J Cyst Fibros; 2013 Dec; 12(6):592-8. PubMed ID: 23764085
[TBL] [Abstract][Full Text] [Related]
23. Glucosylceramide Plays a Role in Fungal Germination, Lipid Raft Organization and Biofilm Adhesion of the Pathogenic Fungus
Rochetti VP; Rollin-Pinheiro R; de Oliveira EB; Xisto MIDDS; Barreto-Bergter E
J Fungi (Basel); 2020 Dec; 6(4):. PubMed ID: 33302332
[TBL] [Abstract][Full Text] [Related]
24. Molecular identification and susceptibility of clinically relevant Scedosporium spp. in China.
Wang H; Wan Z; Li R; Lu Q; Yu J
Biomed Res Int; 2015; 2015():109656. PubMed ID: 26550562
[TBL] [Abstract][Full Text] [Related]
25. Glucosylceramides in Colletotrichum gloeosporioides are involved in the differentiation of conidia into mycelial cells.
da Silva AF; Rodrigues ML; Farias SE; Almeida IC; Pinto MR; Barreto-Bergter E
FEBS Lett; 2004 Mar; 561(1-3):137-43. PubMed ID: 15013765
[TBL] [Abstract][Full Text] [Related]
26. Identification of Pseudallescheria and Scedosporium species by three molecular methods.
Lu Q; Gerrits van den Ende AH; Bakkers JM; Sun J; Lackner M; Najafzadeh MJ; Melchers WJ; Li R; de Hoog GS
J Clin Microbiol; 2011 Mar; 49(3):960-7. PubMed ID: 21177887
[TBL] [Abstract][Full Text] [Related]
27. Susceptibility and diversity in the therapy-refractory genus scedosporium.
Lackner M; Hagen F; Meis JF; Gerrits van den Ende AH; Vu D; Robert V; Fritz J; Moussa TA; de Hoog GS
Antimicrob Agents Chemother; 2014 Oct; 58(10):5877-85. PubMed ID: 25070092
[TBL] [Abstract][Full Text] [Related]
28. Re-identification of clinical isolates of the Pseudallescheria boydii-complex involved in near-drowning.
Tintelnot K; Wagner N; Seibold M; de Hoog GS; Horré R
Mycoses; 2008 Sep; 51 Suppl 3():11-6. PubMed ID: 18782237
[TBL] [Abstract][Full Text] [Related]
29. Isolation and clinical significance of Pseudallescheria and Scedosporium species.
Horré R; Marklein G
Med Mycol; 2009 Jun; 47(4):415-21. PubMed ID: 19291595
[TBL] [Abstract][Full Text] [Related]
30. Tricuspid valve and pacemaker endocarditis due to Pseudallescheria boydii (Scedosporium apiospermum).
Laurini JA; Carter JE; Kahn AG
South Med J; 2009 May; 102(5):515-7. PubMed ID: 19373137
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and susceptibility testing of new species of pseudallescheria and scedosporium in a collection of clinical mold isolates.
Alastruey-Izquierdo A; Cuenca-Estrella M; Monzón A; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2007 Feb; 51(2):748-51. PubMed ID: 17101671
[TBL] [Abstract][Full Text] [Related]
32. Toll-like receptors (TLR2 and TLR4) recognize polysaccharides of Pseudallescheria boydii cell wall.
Figueiredo RT; Bittencourt VC; Lopes LC; Sassaki G; Barreto-Bergter E
Carbohydr Res; 2012 Jul; 356():260-4. PubMed ID: 22507831
[TBL] [Abstract][Full Text] [Related]
33. Pathology of hyalohyphomycosis caused by Scedosporium apiospermum (Pseudallescheria boydii): an emerging mycosis.
Tadros TS; Workowski KA; Siegel RJ; Hunter S; Schwartz DA
Hum Pathol; 1998 Nov; 29(11):1266-72. PubMed ID: 9824105
[TBL] [Abstract][Full Text] [Related]
34. Scedosporium apiospermum (Pseudallescheria boydii) endocarditis.
O'Bryan TA; Browne FA; Schonder JF
J Infect; 2002 Apr; 44(3):189-92. PubMed ID: 12099748
[TBL] [Abstract][Full Text] [Related]
35. Selective isolation of Pseudallescheria and Scedosporium species from respiratory tract specimens of cystic fibrosis patients.
Horré R; Marklein G; Siekmeier R; Nidermajer S; Reiffert SM
Respiration; 2009; 77(3):320-4. PubMed ID: 18957840
[TBL] [Abstract][Full Text] [Related]
36. Pseudallescheria and Scedosporium: emerging opportunists.
Bouchara JP; Horré R; de Hoog S
Med Mycol; 2009 Jun; 47(4):341-2. PubMed ID: 19194819
[No Abstract] [Full Text] [Related]
37. Cutaneous Pseudallescheria boydii/Scedosporium apiospermum Complex (Molecular type: Scedosporium apiospermum [Clade 4]) Infection: A Case Report and Literature Review of Cases from Japan.
Ishii S; Hiruma M; Hayakawa Y; Sugita T; Makimura K; Hiruma M; Yoshiike T
Med Mycol J; 2015; 56(4):E25-30. PubMed ID: 26617105
[TBL] [Abstract][Full Text] [Related]
38. Tracking the emerging human pathogen Pseudallescheria boydii by using highly specific monoclonal antibodies.
Thornton CR
Clin Vaccine Immunol; 2009 May; 16(5):756-64. PubMed ID: 19321690
[TBL] [Abstract][Full Text] [Related]
39. Heterothallism in Scedosporium apiospermum and description of its teleomorph Pseudallescheria apiosperma sp. nov.
Gilgado F; Gené J; Cano J; Guarro J
Med Mycol; 2010 Feb; 48(1):122-8. PubMed ID: 19418347
[TBL] [Abstract][Full Text] [Related]
40. A monoclonal antibody to glucosylceramide inhibits the growth of Fonsecaea pedrosoi and enhances the antifungal action of mouse macrophages.
Nimrichter L; Barreto-Bergter E; Mendonça-Filho RR; Kneipp LF; Mazzi MT; Salve P; Farias SE; Wait R; Alviano CS; Rodrigues ML
Microbes Infect; 2004 Jun; 6(7):657-65. PubMed ID: 15158773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
